Researchers have found that most patients that are prescribed 3 or more antihypertensive medications do not reach BP targets.
Beginning October 1, 2025, the Lumea device integration will be available as an optional feature on the Maestro Encore. On January 1, 2026, it will become a standard feature, ensuring pathology labs ...
Poly Medicure to acquire Italy-based Citieffe Group for Rs. 324 crore: Our Bureau, Mumbai Wednesday, September 24, 2025, 17:30 Hrs [IST] Poly Medicure Ltd., India’s leading medi ...
Most Oregon hospitals have been bleeding cash for years, and at least two are already set to close their obstetrics units.
Rural hospitals were already cutting their obstetrics programs before Republicans in Congress passed a bill to slash Medicaid ...
H1 2025 results Activity and profitability H1 revenue: €387.8 million, down 5.4% at CER1 and on a like-for-like basis2, mainly due to the decline in activity in FranceRestated EBITDA margin3 came ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback